Burke Wealth Management released its “Focused Growth Strategy” Q2 2025 investor letter, showing a +15.9% return compared to S&P 500’s +10.9%. Novo Nordisk A/S (NYSE:NVO) stock closed at $56.98 per share on August 22, with a market cap of $246.974 billion. The company sold its stake in Novo-Nordisk due to market factors.

Novo Nordisk A/S (NYSE:NVO) was held by 45 hedge fund portfolios at the end of Q2, down from 60 in the previous quarter. Despite its potential, AI stocks are seen as offering greater upside with less risk. GreensKeeper Asset Management acquired Novo Nordisk A/S (NVO) in Q2 2025, expecting growth from its GLP-1 products.

In a market marked by significant volatility, Burke Wealth Management’s investment strategy yielded positive returns in Q2 2025. Novo Nordisk A/S (NYSE:NVO) faced challenges leading to strategic decisions by investment firms. Despite a decline in hedge fund holdings, the company remains relevant in discussions about potential investments and market trends.

Read more at Yahoo Finance: Here’s Why Burke Wealth Management Sold Novo Nordisk (NVO)